Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

NCT03571516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: Teduglutide
OTHER: Standard Medical Therapy
DEVICE: Syringe
DEVICE: Needle

Sponsor

Shire